, 1962) and prospective therapeutic effects in individuals. The early clinical trials used largely LSD whilst the vast majority of new hallucinogen experiments applied psilocybin as a consequence of its ease of use mainly because of the shorter motion and less controversial history (Nichols et al Another major challenge is https://socialbookmarkgs.com/story17807320/the-definitive-guide-to-lsd-microdosing-benefits-and-risks